SK12222003A3 - Beta-karbolínové deriváty, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitia proti depresii a úzkosti - Google Patents

Beta-karbolínové deriváty, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitia proti depresii a úzkosti Download PDF

Info

Publication number
SK12222003A3
SK12222003A3 SK1222-2003A SK12222003A SK12222003A3 SK 12222003 A3 SK12222003 A3 SK 12222003A3 SK 12222003 A SK12222003 A SK 12222003A SK 12222003 A3 SK12222003 A3 SK 12222003A3
Authority
SK
Slovakia
Prior art keywords
compound
free base
addition salt
acid addition
anxiety
Prior art date
Application number
SK1222-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Thomas J. Troxler
Konstanze Hurth
Daniel Hoyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK12222003A3 publication Critical patent/SK12222003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1222-2003A 2001-04-03 2002-04-02 Beta-karbolínové deriváty, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitia proti depresii a úzkosti SK12222003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108337.7A GB0108337D0 (en) 2001-04-03 2001-04-03 Organic compounds
PCT/EP2002/003624 WO2002081471A1 (en) 2001-04-03 2002-04-02 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety

Publications (1)

Publication Number Publication Date
SK12222003A3 true SK12222003A3 (sk) 2004-06-08

Family

ID=9912165

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1222-2003A SK12222003A3 (sk) 2001-04-03 2002-04-02 Beta-karbolínové deriváty, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitia proti depresii a úzkosti

Country Status (27)

Country Link
US (1) US6861430B2 (hu)
EP (1) EP1377578B1 (hu)
JP (1) JP4405732B2 (hu)
KR (1) KR100564840B1 (hu)
CN (1) CN1309721C (hu)
AR (1) AR035451A1 (hu)
AT (1) ATE517104T1 (hu)
AU (1) AU2002316828B2 (hu)
BR (1) BR0208566B1 (hu)
CA (1) CA2440014C (hu)
CZ (1) CZ295992B6 (hu)
EC (1) ECSP034754A (hu)
ES (1) ES2368389T3 (hu)
GB (1) GB0108337D0 (hu)
HU (1) HUP0400317A3 (hu)
IL (1) IL157545A0 (hu)
MX (1) MXPA03009057A (hu)
MY (1) MY134026A (hu)
NO (1) NO20034413L (hu)
NZ (1) NZ528370A (hu)
PE (1) PE20021018A1 (hu)
PL (1) PL210861B1 (hu)
PT (1) PT1377578E (hu)
RU (1) RU2003130644A (hu)
SK (1) SK12222003A3 (hu)
WO (1) WO2002081471A1 (hu)
ZA (1) ZA200306108B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
JP4671123B2 (ja) 2003-06-23 2011-04-13 小野薬品工業株式会社 新規三環性複素環化合物
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
EP1829874B1 (en) 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
US7879859B2 (en) 2005-11-21 2011-02-01 Merck Sharp & Dohme Corp. Diagnosis and treatment of type 2 diabetes and other disorders
US20070149557A1 (en) * 2005-11-21 2007-06-28 Amgen Inc. CXCR3 antagonists
EP2178537A4 (en) * 2007-07-19 2011-08-17 Merck Sharp & Dohme BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
WO2009016329A1 (en) * 2007-07-31 2009-02-05 Cambridge Enterprise Limited Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions
WO2009155388A1 (en) 2008-06-20 2009-12-23 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
EP2540297B1 (en) 2008-11-19 2015-04-08 Forum Pharmaceuticals Inc. Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TW201028414A (en) * 2009-01-16 2010-08-01 Merck Sharp & Dohme Oxadiazole beta carboline derivatives as antidiabetic compounds
CA2785790A1 (en) 2010-01-15 2011-07-21 Merck Sharp & Dohme Corp. Oxadiazole beta carboline derivatives as antidiabetic compounds
CN105837566B (zh) 2010-05-17 2018-02-06 富瑞姆制药公司 (R)‑7‑氯‑N‑(奎宁环‑3‑基)苯并[b]噻吩‑2‑甲酰胺盐酸盐单水合物的晶型
EP2846796A4 (en) 2012-05-08 2015-10-21 Forum Pharmaceuticals Inc METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION
CN111349096B (zh) * 2020-04-14 2021-03-09 石河子大学 一种吲哚类化合物及其制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
RU2233841C2 (ru) 1998-06-12 2004-08-10 Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик Сас Бета-карболиновые соединения, фармацевтические композиции на их основе и способы связывания, достижения агонистического/антагонистического эффекта

Also Published As

Publication number Publication date
PL362571A1 (en) 2004-11-02
NO20034413D0 (no) 2003-10-02
ES2368389T3 (es) 2011-11-16
PT1377578E (pt) 2011-09-23
JP2004525178A (ja) 2004-08-19
CA2440014A1 (en) 2002-10-17
ZA200306108B (en) 2004-07-05
NZ528370A (en) 2005-10-28
EP1377578A1 (en) 2004-01-07
BR0208566A (pt) 2004-03-30
PE20021018A1 (es) 2003-01-13
NO20034413L (no) 2003-10-02
RU2003130644A (ru) 2005-04-10
AU2002316828B2 (en) 2006-05-11
GB0108337D0 (en) 2001-05-23
ECSP034754A (es) 2003-10-28
KR100564840B1 (ko) 2006-03-28
CN1500090A (zh) 2004-05-26
MXPA03009057A (es) 2004-02-12
MY134026A (en) 2007-11-30
EP1377578B1 (en) 2011-07-20
HUP0400317A2 (hu) 2004-09-28
JP4405732B2 (ja) 2010-01-27
US6861430B2 (en) 2005-03-01
BR0208566B1 (pt) 2013-12-24
CN1309721C (zh) 2007-04-11
IL157545A0 (en) 2004-03-28
KR20040008150A (ko) 2004-01-28
PL210861B1 (pl) 2012-03-30
CA2440014C (en) 2010-11-23
US20040132735A1 (en) 2004-07-08
CZ20032655A3 (cs) 2003-12-17
CZ295992B6 (cs) 2005-12-14
AR035451A1 (es) 2004-05-26
WO2002081471A1 (en) 2002-10-17
ATE517104T1 (de) 2011-08-15
HUP0400317A3 (en) 2007-10-29

Similar Documents

Publication Publication Date Title
JP5972964B2 (ja) 抗腫瘍剤としての三環式および四環式ピラゾロ［３，４−ｂ］ピリジン化合物
JP5524071B2 (ja) 複素環フェニルアミドｔ型カルシウムチャネルアンタゴニスト
US9045428B2 (en) Substituted heterocyclic compounds
JP2011500808A (ja) 複素環アミドｔ型カルシウムチャネルアンタゴニスト
SK12222003A3 (sk) Beta-karbolínové deriváty, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitia proti depresii a úzkosti
WO2017162007A1 (zh) 芳香族酰胺类衍生物、其制备方法及其在医药上的应用
AU2007311983B2 (en) An Alzheimer' s disease progression inhibitor containing heterocyclic compound
JPH11501925A (ja) 置換Ｎ−アリールメチルおよびヘテロシクリルメチル−１Ｈ−ピラゾロ〔３，４−ｂ〕キノリン−４−アミン並びにそれらを含有する組成物
AU2011288876A1 (en) Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
JP2008537741A (ja) Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびそれらの使用
EP2354139A1 (en) Pyrrolopyridines useful as inhibitors of protein kinase
JP2016520118A (ja) Ｂｅｔ阻害剤としてのピラゾロ−ピロリジン−４−オン誘導体および疾患の処置におけるその使用
JP2011500807A (ja) ピラジニルアミドｔ型カルシウムチャネルアンタゴニスト
HU205354B (en) Process for producing new tricyclic benzimidazoles and pharmaceutical compositions comprising same
JP2008519818A (ja) Ｃｎｓ障害の治療のためのアザベンゾオキサゾール
US20090181986A1 (en) Substituted heterocyclic compounds
AU2002316828A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
JP4285994B2 (ja) 複素環化合物及びそれを有効成分とする脳機能改善剤
KR100820006B1 (ko) 헤테로사이클릭 ｇａｂａ-ａ 아형 선택적 수용체 조절제
JP5898815B2 (ja) 新規なピラゾロピリミジン
TW200924772A (en) Heterobicyclic-substituted quinolones useful as nitric oxide synthase inhibitors
WO2022028556A1 (zh) Cdk9抑制剂及其用途

Legal Events

Date Code Title Description
FC9A Refused patent application